Picture of Immunovia AB (publ) logo

IMMNOV Immunovia AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Immunovia Further Strengthens IP Portfolio For Its IMMray Pancan-D Signature

March 6 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA FURTHER STRENGTHENS IP PORTFOLIO FOR ITS IMMRAY™
PANCAN-D SIGNATURE
    * UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
ISSUED A
NOTICE OF ALLOWANCE FOR PATENT APPLICATION FOR IMMRAY™ PANCAN-D
TEST AVAILABLE EXCLUSIVELY FROM IMMUNOVIA, INC
    * THIS MEANS THAT IMMUNOVIA IMMRAY™ PANCAN-D TEST SIGNATURE
WILL
BE FURTHER COVERED BY RESULTANT PATENT ONCE IT IS ISSUED.

Source text for Eikon:  ID:nWkr80QQ1C 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Immunovia AB (publ)

See all news